Interferon-γ-mediated pathways are induced in human CD34+ haematopoietic stem cells

Immunobiology

Volumn 215, Issue 6, 2010, Pages 452-457

  Kurz, Katharina ^a,b   Gluhcheva, Yordanka ^c   Zvetkova, Elissaveta ^c   Konwalinka, Guenther ^a   Fuchs, Dietmar ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Institute of Experimental Morphology and Anthropology Bulgarian Academy of Sciences   (Bulgaria)

Author keywords

Interferon ; Neopterin; Proliferation; Stem cells; Tryptophan degradation

Indexed keywords

CD34 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEOPTERIN; TRYPTOPHAN;

ARTICLE; BURST FORMING UNIT E; CD34 SELECTION; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SUBPOPULATION; COLONY FORMING UNIT E; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LYMPHOID PROGENITOR CELL; PRIORITY JOURNAL; TRYPTOPHAN METABOLISM;

ANEMIA; ANTIGENS, CD34; ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; GTP CYCLOHYDROLASE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; MONOCYTES; NEOPTERIN; TRYPTOPHAN;

EID: 77952553096     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.08.007     Document Type: Article

References (31)

1. Aizawa S., Hiramoto M., Araki S., Negishi S., Kimura Y., Hoshi H., Kojima S., Wakasugi K. Stimulatory effects of neopterin on hematopoiesis in vitro are mediated by activation of stromal cell function. Hematol. Oncol. 1998, 16:57-67.
2. Aizawa S., Hiramoto M., Araki S., Hoshi H., Kojima S., Wakasugi K. In vivo stimulatory effects of neopterin on hematopoiesis. Pteridines 1998, 9:13-17.
3. Atlas of Human Hematopoietic Colonies, 1995.Stem Cell Technologies Inc., Vancouver, Canada.
4. Casadevall N. Cellular mechanism of resistance to erythropoietin. Nephrol. Dial. Transplant. 1995, 10(Suppl. 6):27-30.
5. Dai C., Krantz S.B. Interferon gamma induces upregulation and activation of caspases 1, 3 and 8 to produce apoptoisi in human erythroid progenitor cells. Blood 1999, 93:3309-3316.
6. Denz H., Fuchs D., Huber H., Nachbaur D., Reibnegger G., Thaler J., Werner E.R., Wachter H. Correlation between neopterin, interferon-gamma and haemoglobin in patients with haematological disorders. Eur. J. Haematol. 1990, 44:186-189.
7. Fuchs D., Shearer G.M., Boswell R.N., Lucey D.R., Clerici M., Reibnegger G., Werner E.R., Zajac R.A., Wachter H. Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS 1991, 5:209-212.
8. Fuchs D., Weiss G., Reibnegger G., Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit. Rev. Clin. Lab. Sci. 1992, 29:307-341.
9. Fuchs D., Zangerle R., Artner-Dworzak E., Weiss G., Fritsch P., Tilz G.P., Dierich M.P., Wachter H. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur. J. Haematol. 1993, 50:90-94.
10. Fuchs D., Zangerle R., Denz H., Wachter H. Inhibitory cytokines in patients with anemia of chronic disorders. Ann. N.Y. Acad. Sci. 1994, 718:344-346.
11. Fuith L.C., Fuchs D., Reibnegger G., Wachter H. Cellular immune activation and erythropoiesis in gynaecological cancer. Lancet 1989, 1:908.
12. Greendyke R.M., Sharma K., Gifford F.R. Serum levels of erythropoietin and selected other cytokines in patients with anemia of chronic disease. Am. J. Clin. Pathol. 1994, 101:338-341.
13. Kanbe E., Hatta Y., Tsuboi I., Harada T., Koshinaga M., Inoue T., Aizawa S. Effects of neopterin on the hematopoietic microenvironment of senescence-accelerated mice (SAM). Biol Pharm Bull. 2006, 29:43-48.
14. Konwalinka G., Geissler D., Peschel C., Tomaschek B., Schmalzl F., Huber H., Odavic R., Braunsteiner H. A micro agar culture system for cloning human erythropoietic progenitors in vitro. Exp. Hematol. 1982, 1:71-77.
15. Mamus S.W., Beck-Schroeder S., Zanjani E.D. Suppression of normal human erythropoiesis by gamma interferon in vitro: role of monocytes and T lymphocytes. J. Clin. Invest. 1985, 75:1496-1503.
16. Means R.T. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 1995, 13:32-37.
17. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619-4621.
18. Minami A., Tsuboi I., Harada T., Fukumoto T., Hiramoto M., Koshinaga M., Hirabayashi Y., Kanno J., Inoue T., Aizawa S. Inflammatory biomarker, neopterin, suppresses B lymphopoiesis for possible facilitation of granulocyte responses, which is severely altered in age-related stromal-cell-impaired mice, SCI/SAM. Exp. Biol. Med. 2007, 232:134-145.
19. Munn D.H., Shafizadeh E., Attwood J.T., Bondarev I., Pashine A., Mellor A.L. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 1999, 189:1363-1372.
20. Selleri C., Maciejewski J.P., Sato T., Young N.S. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition. Blood 1996, 87:4149-4157.
21. Shiohara M., Koike K., Nakahata T., Komiyama A. Hematopoietic progenitors and synergism of interferon-gamma and stem cell factor. Leuk. Lymphoma. 1994, 14:203-211.
22. Taetle R., Honeysett J.M. Gamma-interferon modulates human monocyte/macrophage transferrin receptor expression. Blood 1988, 71:1590-1595.
23. Tsuboi, I., Harada, T., Hirabayashi, Y., Kanno, J., Inoue, T., Aizawa, S., 2009. Inflammatory biomarker, neopterin, predominantly enhances myelopoiesis, which suppresses erythropoiesis via activated stromal cells. Immunobiology (Epub ahead of print).
24. Tsuji K., Muraoka K., Nakahata T. Interferon-gamma and human megakaryopoiesis. Leuk. Lymphoma. 1998, 31:107-113.
25. Wang C.Q., Udupa K.B., Lipschitz D.A. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J. Cell Physiol. 1995, 162:134-138.
26. Weiss G., Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 2005, 352:1011-1023.
27. Weiss G., Schroecksnadel K., Mattle V., Winkler C., Konwalinka G., Fuchs D. Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation. Eur. J. Haematol. 2004, 72:130-134.
28. Widner B., Werner E.R., Schennach H., Wachter H., Fuchs D. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin. Chem. 1997, 43:2424-2426.
29. Wirleitner B., Neurauter G., Schrocksnadel K., Frick B., Fuchs D. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr. Med. Chem. 2003, 10:1581-1591.
30. Zangerle R., Schröcksnadel K., Winkler C., Sarcletti M., Romani N., Banki Z., Ebner S., Fuchs D. Parameters of cellular immune activation in vivo correlate with the proliferative capacity of peripheral blood mononuclear cells in vitro in HIV-infected patients. J. Aquir. Immune Defic. Syndr. 2009, 50:354-359.
31. Zoumbos N.C., Gascon P., Djeu J.Y., Young N.S. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc. Natl. Acad. Sci. USA 1985, 82:188-192.